Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study

被引:0
作者
Jelena Bešević
Marc J Gunter
Renée T Fortner
Konstantinos K Tsilidis
Elisabete Weiderpass
N Charlotte Onland-Moret
Laure Dossus
Anne Tjønneland
Louise Hansen
Kim Overvad
Sylvie Mesrine
Laura Baglietto
Françoise Clavel-Chapelon
Rudolf Kaaks
Krasimira Aleksandrova
Heiner Boeing
Antonia Trichopoulou
Pagona Lagiou
Christina Bamia
Giovanna Masala
Claudia Agnoli
Rosario Tumino
Fulvio Ricceri
Salvatore Panico
HB(as) Bueno-de-Mesquita
Petra H Peeters
Mie Jareid
J Ramón Quirós
Eric J Duell
María-José Sánchez
Nerea Larrañaga
María-Dolores Chirlaque
Aurelio Barricarte
Joana A Dias
Emily Sonestedt
Annika Idahl
Eva Lundin
Nicholas J Wareham
Kay-Tee Khaw
Ruth C Travis
Sabina Rinaldi
Isabelle Romieu
Elio Riboli
Melissa A Merritt
机构
[1] School of Public Health,Department of Epidemiology and Biostatistics
[2] Imperial College London,Division of Cancer Epidemiology
[3] German Cancer Research Center (DKFZ),Department of Hygiene and Epidemiology
[4] University of Ioannina School of Medicine,Department of Community Medicine
[5] University Campus,Department of Research
[6] Faculty of Health Sciences,Department of Medical Epidemiology and Biostatistics
[7] University of Tromsø–The Arctic University of Norway,Department of Public Health
[8] Cancer Registry of Norway,Department of Epidemiology
[9] Karolinska Institutet,Department of Hygiene
[10] Genetic Epidemiology Group,Department of Medical Sciences
[11] Folkhälsan Research Center,Dipartimento di Medicina Clinica e Chirurgia
[12] Julius Center for Health Sciences and Primary Care,Department for Determinants of Chronic Diseases (DCD)
[13] University Medical Center Utrecht,Department of Gastroenterology and Hepatology
[14] Inserm,Department of Social and Preventive Medicine
[15] Center for Research in Epidemiology and Population Health (CESP),Public Health Division of Gipuzkoa
[16] U1018,Department of Epidemiology
[17] Lifestyle,Department of Clinical Sciences Malmö
[18] Genes and Health: Integrative Trans-generational Epidemiology,Department of Clinical Sciences
[19] Université Paris Sud,Department of Public Health and Clinical Medicine
[20] UMRS 1018,Department of Medical Biosciences and Pathology
[21] Institut Gustave Roussy,Nuffield Department of Population Health
[22] Danish Cancer Society Research Center,undefined
[23] Section for Epidemiology,undefined
[24] Aarhus University,undefined
[25] Cancer Epidemiology Center,undefined
[26] Cancer Council of Victoria,undefined
[27] Center for Epidemiology and Biostatistics,undefined
[28] School of Population and Global Health,undefined
[29] University of Melbourne,undefined
[30] German Institute of Human Nutrition Potsdam-Rehbrücke,undefined
[31] Hellenic Health Foundation,undefined
[32] Bureau of Epidemiologic Research,undefined
[33] Academy of Athens,undefined
[34] Epidemiology and Medical Statistics,undefined
[35] University of Athens Medical School,undefined
[36] Molecular and Nutritional Epidemiology Unit,undefined
[37] Cancer Research and Prevention Institute–ISPO,undefined
[38] Epidemiology and Prevention Unit,undefined
[39] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[40] Cancer Registry and Histopathology Unit,undefined
[41] ‘Civic–M.P. Arezzo’ Hospital,undefined
[42] ASP,undefined
[43] Unit of Epidemiology,undefined
[44] Regional Health Service ASL TO3,undefined
[45] Unit of Cancer Epidemiology,undefined
[46] University of Turin,undefined
[47] Federico II University,undefined
[48] National Institute for Public Health and the Environment (RIVM),undefined
[49] University Medical Center Utrecht,undefined
[50] Faculty of Medicine,undefined
来源
British Journal of Cancer | 2015年 / 113卷
关键词
epithelial ovarian cancer; menopausal hormone therapy; survival; oral contraceptives; parity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1622 / 1631
页数:9
相关论文
共 283 条
  • [1] Allemani C(2014)Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 977-1010
  • [2] Weir HK(2008)Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls Lancet 371 303-314
  • [3] Carreira H(2015)Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies Lancet 385 1835-1842
  • [4] Harewood R(1983)Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis J Natl Cancer Inst 71 717-721
  • [5] Spika D(2004)Estrogens and epithelial ovarian cancer Gynecol Oncol 94 25-32
  • [6] Wang XS(2015)Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort Int J Cancer 137 1196-1208
  • [7] Bannon F(1994)Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 515-526
  • [8] Ahn JV(1989)Modeling and variable selection in epidemiologic analysis Am J Public Health 79 340-349
  • [9] Johnson CJ(1993)Reproductive factors and survival from ovarian cancer Int J Cancer 54 904-906
  • [10] Bonaventure A(2008)Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective Histopathology 53 127-138